DE60326989D1 - Orale pharmazeutische zubereitungen enthaltend cyclosporin - Google Patents
Orale pharmazeutische zubereitungen enthaltend cyclosporinInfo
- Publication number
- DE60326989D1 DE60326989D1 DE60326989T DE60326989T DE60326989D1 DE 60326989 D1 DE60326989 D1 DE 60326989D1 DE 60326989 T DE60326989 T DE 60326989T DE 60326989 T DE60326989 T DE 60326989T DE 60326989 D1 DE60326989 D1 DE 60326989D1
- Authority
- DE
- Germany
- Prior art keywords
- carrier
- cyclosporin
- hlb
- aliphatic
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0218003A GB2391472B (en) | 2002-08-02 | 2002-08-02 | Pharmaceutical compositions |
PCT/GB2003/003278 WO2004012770A1 (en) | 2002-08-02 | 2003-07-31 | Oral pharmaceutical compositions comprising cyclosporin |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60326989D1 true DE60326989D1 (de) | 2009-05-14 |
Family
ID=9941656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60326989T Expired - Lifetime DE60326989D1 (de) | 2002-08-02 | 2003-07-31 | Orale pharmazeutische zubereitungen enthaltend cyclosporin |
Country Status (11)
Country | Link |
---|---|
US (1) | US7153834B2 (de) |
EP (1) | EP1572241B1 (de) |
JP (1) | JP2005539002A (de) |
KR (1) | KR101068256B1 (de) |
AT (1) | ATE427123T1 (de) |
AU (1) | AU2003260706A1 (de) |
CA (1) | CA2494761C (de) |
DE (1) | DE60326989D1 (de) |
GB (1) | GB2391472B (de) |
MX (1) | MXPA05001351A (de) |
WO (1) | WO2004012770A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5858401A (en) | 1996-01-22 | 1999-01-12 | Sidmak Laboratories, Inc. | Pharmaceutical composition for cyclosporines |
MX2007011250A (es) * | 2005-03-21 | 2007-11-14 | Ivax Pharmaceuticals Sro | Inhibidor de la cristalizacion y su uso en capsulas de gelatina. |
US7288520B2 (en) | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
US20070015691A1 (en) | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Cyclosporin compositions |
US20070015693A1 (en) * | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Cyclosporin compositions |
US7276476B2 (en) * | 2005-07-13 | 2007-10-02 | Allergan, Inc. | Cyclosporin compositions |
US7297679B2 (en) | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
US7202209B2 (en) | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
US7501393B2 (en) * | 2005-07-27 | 2009-03-10 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
US7745400B2 (en) * | 2005-10-14 | 2010-06-29 | Gregg Feinerman | Prevention and treatment of ocular side effects with a cyclosporin |
US9839667B2 (en) | 2005-10-14 | 2017-12-12 | Allergan, Inc. | Prevention and treatment of ocular side effects with a cyclosporin |
RU2641963C2 (ru) | 2011-11-15 | 2018-01-23 | Аллерган, Инк. | Взвеси циклоспорина а формы 2 |
RU2630970C2 (ru) | 2011-11-15 | 2017-09-15 | Аллерган, Инк. | Автоклавируемые взвеси циклоспорина а формы 2 |
WO2020202149A1 (en) * | 2019-04-01 | 2020-10-08 | Given Imaging Ltd. | In vivo immunoassay system |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI65914C (fi) | 1978-03-07 | 1984-08-10 | Sandoz Ag | Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a |
US5639724A (en) * | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
US5342625A (en) | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
JP3131112B2 (ja) * | 1994-02-17 | 2001-01-31 | 株式会社資生堂 | シクロスポリン含有乳化組成物 |
WO1995022343A1 (fr) * | 1994-02-17 | 1995-08-24 | Shiseido Company, Ltd. | Composition d'emulsion a base de cyclosporine |
US5858401A (en) | 1996-01-22 | 1999-01-12 | Sidmak Laboratories, Inc. | Pharmaceutical composition for cyclosporines |
KR0183449B1 (ko) * | 1996-06-19 | 1999-05-01 | 한스 루돌프 하우스, 니콜 케르커 | 사이클로스포린-함유 연질캅셀제 |
JPH1149664A (ja) * | 1997-04-18 | 1999-02-23 | Taisho Pharmaceut Co Ltd | マイクロエマルション |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6057289A (en) | 1999-04-30 | 2000-05-02 | Pharmasolutions, Inc. | Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system |
EP1170919A1 (de) | 2000-07-04 | 2002-01-09 | TELEFONAKTIEBOLAGET LM ERICSSON (publ) | Verfahren und System zur Verbesserung der Funktion eines Kommunikationssystems mit Schichtprotokollstapel |
-
2002
- 2002-08-02 GB GB0218003A patent/GB2391472B/en not_active Expired - Fee Related
-
2003
- 2003-07-31 MX MXPA05001351A patent/MXPA05001351A/es active IP Right Grant
- 2003-07-31 DE DE60326989T patent/DE60326989D1/de not_active Expired - Lifetime
- 2003-07-31 CA CA2494761A patent/CA2494761C/en not_active Expired - Fee Related
- 2003-07-31 AU AU2003260706A patent/AU2003260706A1/en not_active Abandoned
- 2003-07-31 KR KR1020057001938A patent/KR101068256B1/ko not_active IP Right Cessation
- 2003-07-31 JP JP2004525534A patent/JP2005539002A/ja active Pending
- 2003-07-31 AT AT03766444T patent/ATE427123T1/de not_active IP Right Cessation
- 2003-07-31 WO PCT/GB2003/003278 patent/WO2004012770A1/en active Application Filing
- 2003-07-31 EP EP03766444A patent/EP1572241B1/de not_active Expired - Lifetime
- 2003-08-04 US US10/632,969 patent/US7153834B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE427123T1 (de) | 2009-04-15 |
EP1572241A1 (de) | 2005-09-14 |
KR20050083607A (ko) | 2005-08-26 |
CA2494761A1 (en) | 2004-02-12 |
EP1572241B1 (de) | 2009-04-01 |
KR101068256B1 (ko) | 2011-09-28 |
US20040102366A1 (en) | 2004-05-27 |
GB0218003D0 (en) | 2002-09-11 |
JP2005539002A (ja) | 2005-12-22 |
GB2391472B (en) | 2004-12-08 |
GB2391472A (en) | 2004-02-11 |
WO2004012770A1 (en) | 2004-02-12 |
MXPA05001351A (es) | 2005-10-05 |
AU2003260706A1 (en) | 2004-02-23 |
CA2494761C (en) | 2012-01-24 |
US7153834B2 (en) | 2006-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60326989D1 (de) | Orale pharmazeutische zubereitungen enthaltend cyclosporin | |
ATE355053T1 (de) | Pharmazeutische formulierung mit cyclosporin, propylenglycol-ester und nichtionischem tensid | |
AU2007265836B8 (en) | An effective pharmaceutical carrier for poorly bioavailable drugs | |
JP2001525363A5 (de) | ||
KR20070046819A (ko) | 지질 부형제의 자가 유화 혼합물의 갈레노스 용도 | |
TW200531696A (en) | Pharmaceutical formulations of bisphosphonates | |
US20050187212A1 (en) | Pharmaceutical composition for topical delivery of meloxicam | |
ATE327741T1 (de) | Propofol enthaltende anästhetische zusammensetzung zur intravenösen injektion | |
ES2101574T3 (es) | Composicion administrable por via oral apta para formar una microemulsion. | |
ATE497384T1 (de) | Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen | |
BRPI0612908A2 (pt) | composições farmacêuticas compreendendo inibidores de absorção de colesterol à base de azetidinona e ácidos graxos de Èmega-3 e métodos de tratamento utilizando as mesmas | |
JP2013537185A (ja) | 遊離酸の形のepaおよびdhaを含む脂肪酸油混合物と界面活性剤とスタチンとを含む組成物 | |
CN1261797A (zh) | 自体乳化剂形式的亲脂性化合物的药物组合物 | |
FR2803203B1 (fr) | Nouvelles formulations galeniques du fenofibrate | |
CN1261790A (zh) | 亲脂性化合物的自体乳化剂 | |
CA2494762A1 (en) | Pharmaceutical compositions comprising cyclosporin for oral administration | |
DK1154759T3 (da) | Dispergerbart koncentrat til indgift af cyclosporin | |
HRP20030339A2 (en) | Oral dosage self-emulsifying formulations of pyranone protease inhibitors | |
US8168670B2 (en) | Pyrazolone derivative emulsion formulations | |
ES2551125T3 (es) | Composición antifúngica | |
KR101859200B1 (ko) | 모노아세틸디아실글리세롤 화합물의 경구 투여용 조성물 및 고형 제제 | |
JP6618488B2 (ja) | テストステロンウンデカノエートの安定な製剤 | |
JP2005075804A (ja) | メナテトレノン含有医薬組成物 | |
TW202329947A (zh) | 口服液體恩雜魯胺組成物 | |
US20190247308A1 (en) | Stable liquid formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |